NIAID Funding News


NIAID Funding News provides funding, policy, and other information to NIAID's extramural research community and Institute staff. You can subscribe directly by entering your email address at Email Updates and then selecting your subscription topics. Visit Stay Informed About Policy Changes and News for more opportunities to connect with us.

3D print of a coronavirus spike

Identifying reasonable objectives, or Specific Aims in NIH lingo, is the best way to guide your project's design.

Opportunities and Resources

Phase II or Phase IIB small business grantees and contractors can apply for technical assistance and late-stage research and development support to advance product commercialization.

In The News

On August 14, 2020, NIAID will expire a pair of emergency funding opportunity announcements we issued in late April that solicited R01 and R21 applications for rapid investigation research projects on SARS-CoV-2 and COVID-19.

Applications should not propose COVID-19 pandemic contingency plans, as peer reviewers will not evaluate them. NIH instructed peer reviewers to “assume that temporary, emergency problems arising from the COVID-19 pandemic will be resolved.”

As of July 25, 2020, grantees who submit administrative supplement applications to single- and multi-project awards must submit electronically through using NIH ASSIST, Workspace, or institutional system-to-system solutions.

Registration is open now for NIH's online-only Data Science for Health Discovery and Innovation in Africa Virtual Symposium Platform, which runs through November 2020.

Advice Corner

For non-exempt human subjects research using a single protocol at multiple U.S. sites, you must identify a single institutional review board (sIRB) of record that will conduct the ethical review of your protocol.

Contact Us

Email us at for help navigating NIAID’s grant and contract policies and procedures.